GW Pharmaceuticals Net debt/EBITDA
Was ist das Net debt/EBITDA von GW Pharmaceuticals?
Net debt/EBITDA von GW Pharmaceuticals ist 34.83
Was ist die Definition von Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu GW Pharmaceuticals
Unternehmen mit net debt/ebitda ähnlich GW Pharmaceuticals
- Utz Brands hat Net debt/EBITDA von 34.70
- Yuexiu Property hat Net debt/EBITDA von 34.71
- GTT Communications Inc hat Net debt/EBITDA von 34.74
- Sotherly Hotels Inc hat Net debt/EBITDA von 34.76
- eCargo hat Net debt/EBITDA von 34.81
- American Campus Communities hat Net debt/EBITDA von 34.81
- GW Pharmaceuticals hat Net debt/EBITDA von 34.83
- Trustmark hat Net debt/EBITDA von 34.85
- Midwest Emissions hat Net debt/EBITDA von 34.86
- Armada Hoffler Properties hat Net debt/EBITDA von 34.87
- China Taiping Insurance hat Net debt/EBITDA von 34.91
- Eastman Kodak Co hat Net debt/EBITDA von 34.91
- Lifetime Brands hat Net debt/EBITDA von 34.94